Pharmaceutical / Drug Definition :
Inhibits conversion of angiotensin I to angiotensin II, a vasoconstrictor that stimulates adrenal glands and promotes aldosterone secretion, thereby reducing sodium and water reabsorption and ultimately decreasing blood pressure. Decreased angiotensin also causes increased potassium level and fluid loss.
FDA Label Requirements and Exceptions
Benazepril Hydrochloride
FDA Import Information
Benazepril Hydrochloride
FDA Detentions
Benazepril Hydrochloride (Benazepril Hydrochloride Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Benazepril Hydrochloride (Benazepril Hydrochloride Suppliers)
- Processors Benazepril Hydrochloride
- Repackers Benazepril Hydrochloride
- Relabelers Benazepril Hydrochloride
- Exporters Benazepril Hydrochloride
- Importers Benazepril Hydrochloride
For more information about Benazepril Hydrochloride, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
